查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869910

智慧注射器市场规模、份额和趋势分析报告：按产品、分销管道、应用、技术、地区和细分市场预测（2025-2033 年）

Smart Syringes Market Size, Share & Trends Analysis Report By Product (Auto-Disable Syringes, Passive Safety Syringes), By Distribution Channel, By Application, By Technology, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

智慧注射器市场摘要

2024年全球智慧注射器市场规模估计为10.5亿美元，预计到2033年将达到22.2亿美元。

预计从 2025 年到 2033 年，该行业将以 8.7% 的复合年增长率成长。这一增长是由人们对患者和医护人员安全的日益关注所驱动的，特别是由于针刺伤 (NSI) 的增加以及 HIV 和肝炎等血液传播疾病的传播。

政府主导的疫苗宣传活动和免疫倡议，特别是像印度全民免疫计划（UIP）这样的项目，正在推动对自动失效智慧注射器的需求。此外，美国和欧洲的监管机构正在强制要求使用安全设计的注射器，鼓励医疗机构采用智慧注射器。智慧注射器融合了自动存储和自动失效等安全设计功能，显着降低了意外针刺伤的风险。这已成为一项重大的公共卫生挑战，尤其对医院和诊所的医护人员而言。例如，《国际外科全球健康杂誌》2024年的报告指出，针刺伤（NSI）主要发生在内科和外科，占所有针刺伤事件的50%以上。

高风险区域包括创伤/急诊室（38%）和手术室（3%）。在导致针刺伤的主要产品中，糖尿病患者的胰岛素是罪魁祸首之一。医护人员，包括急救人员、外科医师和护士，尤其面临风险。在全球范围内，护理师的针刺伤发生率估计为42.8%，医生为46.4%，护理专业学生为45.3%。虽然护理师的针刺伤发生率通常在41%左右，但护理专业学生的发生率差异很大，从8.7%到71%不等。

国际社会为提高免疫接种覆盖率所做的努力，尤其是在发展中地区，显着提升了对一次性智慧注射器的需求。这些注射器专为一次性使用而设计，有效防止重复使用，从而提高了疫苗安全性。在印度，全民免疫计画（UIP）是规模最大的公共卫生计画之一，每年涵盖约2,670万新生儿和2,900万孕妇。 UIP被公认为最具成本效益的卫生干预措施之一，已显着降低了五岁以下儿童因疫苗可预防疾病导致的死亡率。

爱滋病毒、B型肝炎病毒（HBV）和丙型肝炎病毒（HCV）等血液传播疾病的日益增多是智慧注射器市场的主要驱动力。不安全的注射操作，包括重复使用注射器和针头，是造成这些感染疾病传播的重要因素，尤其是在开发中国家和医疗资源匮乏的地区。智慧注射器，包括自毁式和安全型设计，旨在防止重复使用和意外针刺伤，在降低感染风险方面发挥着至关重要的作用。

目录

第一章调查方法和范围

第二章执行摘要

第三章 智慧注射器市场变数、趋势与范围

  • 市场体系展望
    • 补贴市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 智慧注射器市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章：智慧注射器市场：产品估算与趋势分析

  • 细分仪表板
  • 智慧注射器市场：产品差异分析及市场占有率（2024 年及 2033 年）
  • 自动禁用注射器
  • 被动安全注射器
  • 主动安全注射器

第五章：智慧注射器市场：应用预测与趋势分析

  • 细分仪表板
  • 智慧注射器市场：应用变化分析及市场占有率（2024 年及 2033 年）
  • 药物输送
    • 胰岛素
    • 疫苗
    • 荷尔蒙疗法
    • 肿瘤药物
    • 其他的
  • 血液检体采集
  • 导管注射器冲洗
  • 其他特殊注射

第六章：智慧注射器市场：通路估算与趋势分析

  • 细分仪表板
  • 智慧注射器市场：通路变化分析及市场占有率（2024 年及 2033 年）
  • 直接竞标（政府和非政府组织）
  • 医院药房
  • 零售药房
  • 网路药房

第七章：智慧注射器市场：技术预测与趋势分析

  • 细分仪表板
  • 智慧注射器市场：技术变革分析及市场占有率（2024 年及 2033 年）
  • 伸缩式技术
  • 针头保护装置技术

第八章 智慧注射器市场：按产品、应用、分销管道和技术分類的区域估算和趋势分析

  • 区域展望
  • 智慧注射器市场：区域差异分析及市场占有率（2024 年及 2033 年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 市场参与企业分类
  • 主要企业简介
    • Becton, Dickinson and Company（BD）
    • Hindustan Syringes &Medical Devices（HMD）
    • Terumo Corporation
    • Nipro Corporation
    • Retractable Technologies, Inc.
    • SCHOTT Pharma
    • Schreiner MediPharm
    • Gerresheimer AG
    • SPM Medicare
    • Restek Corporation
    • Shimadzu
    • Trajan LPP
    • Liaoning Kangyi Medical Equipment Co., Ltd
    • AccuPoint（AdvaCare Pharma）
    • Agilent
  • 热力图分析/企业市场分析
  • 2024年企业市占率预测分析
Product Code: 978-1-68038-896-1

Smart Syringes Market Summary

The global smart syringes market size was estimated at USD 1.05 billion in 2024 and is projected to reach USD 2.22 billion by 2033, growing at a CAGR of 8.7% from 2025 to 2033. The growth is attributed to the increasing focus on patient and healthcare worker safety, particularly with the rise in Needle Stick Injuries (NSIs) and the transmission of blood-borne infections such as HIV and hepatitis.

Government-led vaccination drives and immunization initiatives, especially in countries such as India through the Universal Immunization Programme (UIP), have accelerated demand for auto-disable smart syringes. Moreover, regulatory bodies across the U.S. and Europe have mandated the use of safety-engineered injection devices, pushing healthcare facilities toward smart syringe adoption. Smart syringes have safety-engineered features such as retractable needles or auto-disable mechanisms, significantly reducing the risk of accidental needle-stick injuries. This has become a major public health priority, especially among healthcare workers in hospitals and clinics. For Instance, according to a report by International Journal of Surgery Global Health in 2024, Needlestick injuries (NSIs) are predominantly reported in medical and surgical departments, accounting for over 50% of all incidents.

High-risk areas include trauma and emergency rooms (38%) and operating rooms (3%). Among the key products contributing to NSIs, insulin administration in diabetic patients is a significant cause. Healthcare professionals such as emergency personnel, surgeons, and nurses are particularly at risk. Globally, the prevalence of NSIs is estimated at 42.8% among nurses, 46.4% among doctors, and 45.3% among nursing students. In general, NSI rates among nurses are approximately 41%, while nursing student rates vary widely from 8.7% to 71%.

Global initiatives aimed at expanding immunization coverage, particularly in developing regions, are significantly boosting the demand for auto-disable smart syringes. These syringes are designed for single use, effectively preventing reuse and enhancing vaccine safety. In India, the Universal Immunization Programme (UIP) is one of the largest public health efforts, reaching approximately 26.7 million newborns and 29 million pregnant women annually. Recognized as one of the most cost-effective health interventions, the UIP has significantly reduced under-five mortality rates caused by vaccine-preventable diseases.

The rising incidence of blood-borne infections such as HIV, hepatitis B (HBV), and hepatitis C (HCV) is a major driver for the smart syringe market. Unsafe injection practices, including the reuse of syringes and needles, are significant contributors to the spread of these infections, especially in developing and resource-limited healthcare settings. Smart syringes, including auto-disable and safety-engineered models, are designed to prevent reuse and accidental needlestick injuries, thereby playing a critical role in reducing transmission risks.

Global Smart Syringes Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global smart syringes market report based on product, application, distribution channel, technology, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Auto-Disable Syringes
  • Active Safety Syringes
  • Passive Safety Syringes
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Delivery
    • Insulin
    • Vaccines
    • Hormonal Therapies
    • Oncology Drugs
    • Others
  • Blood Specimen Collection
  • Catheter Syringe Flushing
  • Other Specialized Injection
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Direct Tenders (Government & NGOs)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Needle Retractable Technology
  • Needle Shielding Technology
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Purchased Database.
  • 1.5. GVR's Internal Database
  • 1.6. Secondary Sources
  • 1.7. Third Party Perspective
  • 1.8. Primary Research
  • 1.9. Details of Primary Research
  • 1.10. Information or Data Analysis
  • 1.11. Data Analysis Models
  • 1.12. Market Formulation & Validation
  • 1.13. Model Details
  • 1.14. Commodity Flow Analysis (Model 1)
    • 1.14.1. Approach 1: Commodity Flow Approach
  • 1.15. Volume Price Analysis (Model 2)
    • 1.15.1. Approach 2: Volume Price Analysis
  • 1.16. List of Secondary Sources
  • 1.17. List of Primary Sources
  • 1.18. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Smart Syringes Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Incidence of Needlestick Injuries (Nsis)
      • 3.2.1.2. Government Immunization Programs
      • 3.2.1.3. Technological Innovations
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Smart Syringes
      • 3.2.2.2. Lack of Awareness in Developing Countries
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Increased Focus On Safe Injection Practices
      • 3.2.3.2. Rising Demand in Homecare Settings
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Limited Reusability
  • 3.3. Smart Syringes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining Power of Suppliers
      • 3.3.1.2. Bargaining Power of Buyers
      • 3.3.1.3. Threat of Substitutes
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape

Chapter 4. Smart Syringes Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Smart Syringes Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Auto-Disable Syringes
    • 4.3.1. Auto-Disable Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Passive Safety Syringes
    • 4.4.1. Passive Safety Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Active Safety Syringes
    • 4.5.1. Active Safety Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Smart Syringes Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Smart Syringes Market: Application Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Drug Delivery
    • 5.3.1. Drug Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Insulin
      • 5.3.2.1. Insulin Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.3. Vaccines
      • 5.3.3.1. Vaccines Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.4. Hormonal Therapies
      • 5.3.4.1. Hormonal Therapies Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.5. Oncology Drugs
      • 5.3.5.1. Oncology Drugs Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.6. Others
      • 5.3.6.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.4. Blood Specimen Collection
    • 5.4.1. Blood Specimen Collection Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.5. Catheter Syringe Flushing
    • 5.5.1. Catheter Syringe Flushing Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.6. Other Specialized Injection
    • 5.6.1. Other Specialized Injection Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. Smart Syringes Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Smart Syringes Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Direct Tenders (Government & NGOs)
    • 6.3.1. Direct Tenders (Government & NGOs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Smart Syringes Market: Technology Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Smart Syringes Market: Technology Movement Analysis & Market Share, 2024 & 2033
  • 7.3. Needle Retractable Technology
    • 7.3.1. Needle Retractable Technology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Needle Shielding Technology
    • 7.4.1. Needle Shielding Technology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Smart Syringes Market: Regional Estimates & Trend Analysis by Product, Application, Distribution Channel, Technology

  • 8.1. Regional Outlook
  • 8.2. Smart Syringes Market: Regional Movement Analysis & Market Share, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Scenario
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. U.S. Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Scenario
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Canada Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Scenario
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Mexico Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. UK Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Germany Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Scenario
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. France Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Scenario
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Italy Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Scenario
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Spain Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Scenario
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Denmark Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Scenario
      • 8.4.8.4. Reimbursement Scenario
      • 8.4.8.5. Sweden Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Scenario
      • 8.4.9.4. Reimbursement Scenario
      • 8.4.9.5. Norway Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Japan Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. China Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Scenario
      • 8.5.4.4. Reimbursement Scenario
      • 8.5.4.5. India Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Scenario
      • 8.5.5.4. Reimbursement Scenario
      • 8.5.5.5. South Korea Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Scenario
      • 8.5.6.4. Reimbursement Scenario
      • 8.5.6.5. Australia Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Scenario
      • 8.5.7.4. Reimbursement Scenario
      • 8.5.7.5. Thailand Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Brazil Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Argentina Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. Middle East & Africa Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Scenario
      • 8.7.2.4. Reimbursement Scenario
      • 8.7.2.5. South Africa Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Scenario
      • 8.7.3.4. Reimbursement Scenario
      • 8.7.3.5. Saudi Arabia Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Scenario
      • 8.7.4.4. Reimbursement Scenario
      • 8.7.4.5. UAE Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Scenario
      • 8.7.5.4. Reimbursement Scenario
      • 8.7.5.5. Kuwait Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Becton, Dickinson and Company (BD)
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Hindustan Syringes & Medical Devices (HMD)
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Product Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Terumo Corporation
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Product Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Nipro Corporation
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Product Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Retractable Technologies, Inc.
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Product Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. SCHOTT Pharma
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Product Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Schreiner MediPharm
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Product Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Gerresheimer AG
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Product Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. SPM Medicare
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Product Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Restek Corporation
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Product Benchmarking
      • 9.2.10.4. Strategic Initiatives
    • 9.2.11. Shimadzu
      • 9.2.11.1. Company Overview
      • 9.2.11.2. Financial Performance
      • 9.2.11.3. Product Benchmarking
      • 9.2.11.4. Strategic Initiatives
    • 9.2.12. Trajan LPP
      • 9.2.12.1. Company Overview
      • 9.2.12.2. Financial Performance
      • 9.2.12.3. Product Benchmarking
      • 9.2.12.4. Strategic Initiatives
    • 9.2.13. Liaoning Kangyi Medical Equipment Co., Ltd
      • 9.2.13.1. Company Overview
      • 9.2.13.2. Financial Performance
      • 9.2.13.3. Product Benchmarking
      • 9.2.13.4. Strategic Initiatives
    • 9.2.14. AccuPoint (AdvaCare Pharma)
      • 9.2.14.1. Company Overview
      • 9.2.14.2. Financial Performance
      • 9.2.14.3. Product Benchmarking
      • 9.2.14.4. Strategic Initiatives
    • 9.2.15. Agilent
      • 9.2.15.1. Company Overview
      • 9.2.15.2. Financial Performance
      • 9.2.15.3. Product Benchmarking
      • 9.2.15.4. Strategic Initiatives
  • 9.3. Heat Map Analysis/ Company Market Position Analysis
  • 9.4. Estimated Company Market Share Analysis, 2024

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America smart syringes market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 5 North America smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 6 North America smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 7 North America smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 8 U.S smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 9 U.S smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 10 U.S smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11 U.S smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 12 Canada smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 13 Canada smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 15 Canada smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 16 Mexico smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 19 Mexico smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 20 Europe smart syringes market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 22 Europe smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 23 Europe smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 24 Europe smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 25 UK smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 26 UK smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 27 UK smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 28 UK smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 29 Germany smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 30 Germany smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 31 Germany smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32 Germany smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 33 France smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 34 France smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 35 France smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 36 France smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 37 Italy smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 38 Italy smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 39 Italy smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 40 Italy smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 41 Spain smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 42 Spain smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 43 Spain smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 44 Spain smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 45 Denmark smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 46 Denmark smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 47 Denmark smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 48 Denmark smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 49 Sweden smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 50 Sweden smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 51 Sweden smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 52 Sweden smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 53 Norway smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 54 Norway smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 55 Norway smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 56 Norway smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific smart syringes market, by country, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 62 China smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 63 China smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 64 China smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 65 China smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 66 Japan smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 67 Japan smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 68 Japan smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 69 Japan smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 70 India smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 71 India smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 72 India smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 73 India smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 74 South Korea smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 75 South Korea smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 76 South Korea smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 77 South Korea smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 78 Australia smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 79 Australia smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 80 Australia smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 81 Australia smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 82 Thailand smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 83 Thailand smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 84 Thailand smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 85 Thailand smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 86 Latin America smart syringes market, by country, 2021 - 2033 (USD Million)
  • Table 87 Latin America smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 88 Latin America smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 89 Latin America smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 90 Latin America smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 91 Brazil smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 92 Brazil smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 93 Brazil smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 94 Brazil smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 95 Mexico smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 96 Mexico smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 97 Mexico smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 98 Mexico smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 99 Argentina smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 100 Argentina smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 101 Argentina smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 102 Argentina smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 103 Middle East & Africa smart syringes market, by country, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 108 South Africa smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 109 South Africa smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 110 South Africa smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 111 South Africa smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 116 UAE smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 117 UAE smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 118 UAE smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 119 UAE smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 120 Kuwait smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 121 Kuwait smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 122 Kuwait smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 123 Kuwait smart syringes market, by technology, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Smart syringes market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement process
  • Fig. 5 Primary research pattern
  • Fig. 6 Smart syringes market snapshot, 2024 (USD Million)
  • Fig. 7 Segment snapshot, USD Million
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Penetration & growth prospect mapping, by distribution channel
  • Fig. 10 Market driver analysis (Current & future impact)
  • Fig. 11 Market restraint analysis (Current & future impact)
  • Fig. 12 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Auto-disable syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Passive safety syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Active safety syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Drug delivery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Insulin market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Vaccines market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Hormonal therapies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Oncology drugs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Blood specimen collection market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Catheter syringe flushing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Other specialized injection market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Direct tenders (government & NGOs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Hospital pharmacies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Retail pharmacies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Online pharmacies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Needle retractable technology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Needle shielding technology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Smart syringes market: Regional key takeaways (USD Million)
  • Fig. 32 Smart syringes market: Regional outlook, 2021 & 2033 (USD Million)
  • Fig. 33 North America smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Canada smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Mexico smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Europe smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 UK smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Germany smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 France smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Spain smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Italy smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Sweden smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Norway smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Denmark smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Asia Pacific smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 China smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Japan smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 India smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 South Korea smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Australia smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Thailand smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Latin America smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Brazil smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Argentina smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Middle East and Africa smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 South Africa smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Saudi Arabia smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 UAE smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Kuwait smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Company market share analysis, 2024
  • Fig. 62 Market differentiators
  • Fig. 63 Competitive dashboard analysis
  • Fig. 64 Regional network map